Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 5/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.41 |
| ▸ | ASPH | Q12797 | 2/20 | 0.41 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16277625 | 1.00 | HCRTR1 (0.42) | HCRTR1CES2CES1KDM4EKEAP1 | |
| SCHEMBL16277496 | 0.86 | MYC (0.43) | HCRTR1KDM4EKEAP1ASPHKDM8 | |
| SCHEMBL16463711 | 0.85 | HCRTR1 (0.39) | HCRTR1KDM4EKEAP1ASPHKDM8 | |
| SCHEMBL29424909 | 0.79 | MYC (0.41) | KDM4EKEAP1ASPHKDM8NFE2L2 | |
| SCHEMBL29628873 | 0.77 | ALB (0.50) | HCRTR1HCRTR2CYP1A2KCNH2NAPRT | |
| SCHEMBL1586067 | 0.77 | ALB (0.50) | HCRTR1HCRTR2CYP1A2KCNH2NAPRT | |
| SCHEMBL17007090 | 0.76 | NOTUM (0.40) | HCRTR1CES2CES1KDM4EKEAP1 | |
| SCHEMBL19472425 | 0.74 | KDM4E (0.43) | HCRTR1KDM4EKEAP1ASPHKDM8 | |
| SCHEMBL1586913 | 0.74 | HCRTR1 (0.49) | HCRTR1KEAP1HCRTR2CYP1A2 | |
| SCHEMBL30361760 | 0.74 | KDM4E (0.43) | HCRTR1KDM4EKEAP1ASPHKDM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11324724-B2 | N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11324724-B2 | N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides | HCRTR2, HCRTR1, CNR2 | HCRTR1 2/4885CES2 1259/4885CES1 942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.